Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
54.15
-0.48 (-0.88%)
At close: Sep 18, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $346.31 billion as of September 18, 2026. Its market cap has increased by 30.49% in one year.
Market Cap
346.31B
Enterprise Value
379.83B
Revenue
77.92B
Ranking
n/a
PE Ratio
22.67
Stock Price
$54.15
ChartMarket Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 346.31B, an increase of 3,853.87%. That is a compound annual growth rate of 11.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 346.31B | 4.46% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 831.00M |
| Silence Therapeutics | 764.66M |
| Nika Pharmaceuticals | 431.19M |
| American Oncology Network | 371.06M |
| CytoDyn | 301.57M |
| Northwest Biotherapeutics | 282.44M |
| Elite Pharmaceuticals | 269.18M |
| Scientist Home Future Health | 234.79M |